277 related articles for article (PubMed ID: 35455287)
1. Correlations between Circulating and Tumor-Infiltrating CD4
Al-Mterin MA; Murshed K; Elkord E
Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455287
[TBL] [Abstract][Full Text] [Related]
2. Correlations between Circulating and Tumor-Infiltrating CD4
Al-Mterin MA; Murshed K; Elkord E
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146549
[TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
Front Immunol; 2019; 10():2936. PubMed ID: 31921188
[TBL] [Abstract][Full Text] [Related]
4. Associations of different immune checkpoints-expressing CD4
Al-Mterin MA; Murshed K; Alsalman A; Abu-Dayeh A; Elkord E
BMC Cancer; 2022 Jun; 22(1):601. PubMed ID: 35655158
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral FoxP3
Syed Khaja AS; Toor SM; El Salhat H; Ali BR; Elkord E
Front Immunol; 2017; 8():619. PubMed ID: 28603527
[TBL] [Abstract][Full Text] [Related]
6. Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8
Alsalman A; Al-Mterin MA; Murshed K; Alloush F; Al-Shouli ST; Toor SM; Elkord E
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804964
[TBL] [Abstract][Full Text] [Related]
7. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
[TBL] [Abstract][Full Text] [Related]
8. Differences in Maturation Status and Immune Phenotypes of Circulating Helios
Zhang Y; Zhang J; Shi Y; Shen M; Lv H; Chen S; Feng Y; Chen H; Xu X; Yang T; Xu K
Front Immunol; 2021; 12():628504. PubMed ID: 34054801
[TBL] [Abstract][Full Text] [Related]
9. Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.
Abd Al Samid M; Chaudhary B; Khaled YS; Ammori BJ; Elkord E
Oncotarget; 2016 Mar; 7(12):14083-94. PubMed ID: 26885615
[TBL] [Abstract][Full Text] [Related]
10. IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
Müller M; Herrath J; Malmström V
Clin Exp Immunol; 2015 Oct; 182(1):90-100. PubMed ID: 26076982
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Regulatory T Cell Subsets and Their Expression of Helios and PD-1 in Patients with Hashimoto Thyroiditis.
Hu Y; Zhang L; Chen H; Liu X; Zheng X; Shi H; Jiang L; Cui D
Int J Endocrinol; 2019; 2019():5368473. PubMed ID: 31214258
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4
Saleh R; Toor SM; Khalaf S; Elkord E
Vaccines (Basel); 2019 Oct; 7(4):. PubMed ID: 31614877
[No Abstract] [Full Text] [Related]
13. Transcriptomic Profiling of Tumor-Infiltrating CD4
Sasidharan Nair V; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Soofi ME; Ouararhni K; Alajez NM; Abu Nada M; Elkord E
Vaccines (Basel); 2020 Feb; 8(1):. PubMed ID: 32041340
[TBL] [Abstract][Full Text] [Related]
14. FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children.
Khaitan A; Kravietz A; Mwamzuka M; Marshed F; Ilmet T; Said S; Ahmed A; Borkowsky W; Unutmaz D
J Acquir Immune Defic Syndr; 2016 Aug; 72(5):474-84. PubMed ID: 27003495
[TBL] [Abstract][Full Text] [Related]
15. Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP.
Elkord E; Abd Al Samid M; Chaudhary B
Oncotarget; 2015 Aug; 6(24):20026-36. PubMed ID: 26343373
[TBL] [Abstract][Full Text] [Related]
16. Low expressions of PD-L1 and CTLA-4 by induced CD4
Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
[TBL] [Abstract][Full Text] [Related]
17. Foxp3
Liu L; Zhang Q; Chen P; Guo N; Song A; Huang X; Xia W; Li L; Moog C; Wu H; Su B; Zhang T
BMC Immunol; 2019 Oct; 20(1):38. PubMed ID: 31651258
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
[TBL] [Abstract][Full Text] [Related]
19. In-vitro effect of pembrolizumab on different T regulatory cell subsets.
Toor SM; Syed Khaja AS; Alkurd I; Elkord E
Clin Exp Immunol; 2018 Feb; 191(2):189-197. PubMed ID: 28963773
[TBL] [Abstract][Full Text] [Related]
20. Upregulated TIGIT
Lin F; Hu X; Zhang Y; Ye S; Gu Y; Yan B; Wang L; Jiang Y
Mol Immunol; 2022 Jul; 147():40-49. PubMed ID: 35504057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
